Nurix advances CLL therapy with NX-5948 showing 83% response, 22.1-month PFS, $680M cash, and $3B risk-adjusted sales ...
The site will include a massive foundation, a lifting platform, and worker facilities. Although it will be built to handle a ...
Our Personality Behind the Profile series, showcasing some of the most influential and popular social media profiles in the ...
John Kimmet General Manager of AOP Health US WILMINGTON, Del., Jan. 12, 2026 (GLOBE NEWSWIRE) -- AOP Health US, LLC announced today that Rapiblyk™ (landiolol) is now more widely available across the ...
The futures are trading modestly higher as we get set to wrap up the first complete trading week of 2026, which could finish ...